Latin America in Vitro diagnostics  Market

Latin America In Vitro Diagnostics Market Size, Share, Growth Analysis, By Product(Instrument, reagents, software), By Technology(Immunochemistry, molecular diagnostics, clinical chemistry, hematology.), By Application(Infectious Diseases, Diabetes, Oncology, Cardiology.), By End Users(Hospitals, laboratories, homecare), By Region - Industry Forecast 2025-2032


Report ID: SQMIC35E2046 | Region: Country | Published Date: February, 2024
Pages: 157 | Tables: 119 | Figures: 77

Latin America In Vitro Diagnostics Market News

  • In February 2022, Thermo Fisher Scientific Inc. launched the Renvo Rapid PCR Test to detect in air SARS CoV 2 pathogens.
  • In March 2021, F. Hoffmann-La Roche Ltd launched Cobas pulse point-of-care blood glucose testing instrument.
  • In March 2021, F. Hoffmann-La Roche Ltd. Merge with GenMark Diagnostics Inc. to test for a broad range of pathogens with one patient sample.
$3,500
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Latin America In Vitro Diagnostics Market size was valued at USD 76000 million in 2019 and is poised to grow from USD 136673.76 million in 2023 to USD 106914.16 million by 2031, growing at a CAGR of 4.08% in the forecast period (2024-2031).

Latin America in vitro diagnostics market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Roche Diagnostics', 'Abbott Laboratories', 'Siemens Healthineers', 'Beckman Coulter', 'Bio-Rad Laboratories', 'BD Diagnostics', 'Sysmex Corporation', 'Thermo Fisher Scientific', 'Ortho Clinical Diagnostics', 'Danaher Corporation', 'Hologic', 'Quidel Corporation', 'BioMérieux SA', 'Grifols SA', 'Nova Biomedical Corporation', 'Mindray Medical International Limited', 'BioKit SA', 'SA Scientific', 'Hardy Diagnostics', 'Alfa Scientific Designs Inc..'

The increasing rate of diseases, such as genetic, cardiovascular, and neurological diseases has increased demand for the diagnostics market. Early diagnosis, increasing population, and an increase in routine diagnosis, will drive the vitro diagnostics market growth in Latin America.

Personalized healthcare and advancements in genomics and proteomics are new emerging trends in Latin America in vitro diagnostics market. The increasing adoption of diagnostic devices and technology are increasing market growth in the Latin America region. Also increased need for daily diagnosis are boosting the demand for the market.

Brazil dominated the Latin America in vitro diagnostics market and held a revenue share of over 42.0% in 2021. It is due to increasing demand for unified healthcare infrastructure such as the SUS, growing focus of key market players for investment in this region. In addition, favorable reimbursement policies pertaining towards diagnostic tests.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Latin America in Vitro diagnostics  Market

Report ID: SQMIC35E2046

$3,500
BUY NOW GET FREE SAMPLE